 |
Obsidian Therapeutics
Last updated: October 06, 2024
Paul Wotton, CEO
USA | Funding: $325M (+)
Website: https://obsidiantx.com/
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Website: https://obsidiantx.com/
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
